Navigation Links
University of Toronto chemistry technology promises more effective prescription drug therapies
Date:5/5/2011

TORONTO, ON Scientists at the University of Toronto, Stanford and Columbia Universities have developed a way to measure the action and function of candidate prescription drugs on human cells, including the response of individual cells, more quickly and on a larger scale than ever before.

The researchers say their "mass cytometry" technology has the potential to transform the understanding of a variety of diseases and biologic actions, and will provide a better tool to understand how a healthy cell becomes diseased. Clarifying the underlying biochemistry of cells may enable earlier detection of illness and ultimately advance personalized medicine, notably for cancer and HIV treatments, by offering more and less aggressive options for treatment.

"We've shown that drug response is specific to certain sub-populations of cells, and gained insight into the signaling cascade that defines that response" says Scott Tanner of U of T's Department of Chemistry, who led the development of the technology used in research to be published this week in Science. "We've also shown that a drug can activate or suppress multiple response pathways simultaneously, and that these responses are modified when a combination of drugs are administered."

"Together, this suggests that the technology will be of significant value in the development and validation of rational drugs to target particular pathogens a quantum step towards the provision of personalized medicine," says Tanner.

Mass cytometry allows simultaneous measurement of as many as 100 biomarkers specific physical traits of cells used to measure or indicate the effects or progress of a disease, illness, or condition in single cells, at 1000 cells per second. It applies the analytical capabilities of atomic mass spectrometry used to measure the number and type of atoms that comprise a sample to the technique of flow cytometry, which is a method of examining thousands of microscopic particles per second by suspending them in a stream of fluid or gas and passing them through an electronic detection apparatus. The two very disparate disciplines previously had no reason to be combined.

The U of T scientists developed the chemistry and methods of attaching the metal atoms necessary for the detection of the vanishingly rare biomolecules of interest at the individual cell level, where personal therapeutic response is defined. They also developed a unique instrument to simultaneously measure a large number of these diagnostic signals for individual cells at a high analysis rate. Garry Nolan, a professor of microbiology and immunology at Stanford University and lead investigator of the research presented in this paper, adapted and expanded his earlier work in flow cytometry to take advantage of the much higher power that mass cytometry provides.

Nolan and his colleagues at Stanford, with collaborators at Columbia, used the U of T technology to monitor 34 different substances found inside and on the surface of different cell types produced in human bone marrow, the place where all immune and blood cells, as well as blood disorders such as leukemia, originate. They were able not only to correctly categorize over a dozen different immune cell types but, at the same time, to peer inside the cells and learn how various internal processes differed from one cell type to the next. "We can tell not only what kind of cell it is but what it's thinking, and what it may become," says Nolan.


'/>"/>

Contact: Sean Bettam
s.bettam@utoronto.ca
416-946-7950
University of Toronto
Source:Eurekalert  

Related biology technology :

1. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
2. The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium
3. CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011
4. Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas
5. Nanocrystal doping developed by Hebrew University researchers enhances semiconductor nanocrystals
6. Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome
7. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
8. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
9. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
10. Queens University professor uses nanotechnology to prolong machine and engine life
11. Binghamton University nanoscientist chosen for the Air Forces Young Investigator Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Toronto chemistry technology promises more effective prescription drug therapies
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):